Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients

NCT05762900 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
65
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences